Type 2 Diabetes Archives - The Cardiology Advisor

A doctor and nurse making rounds in a hospital room.

Metabolic

Subjective Cognitive Impairment Associated With Major Adverse CV Events in Patients With T2D

May 18, 2022

For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.

Metabolic

Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes

By

Maria Arini Lopez

May 11, 2022

Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.

A vegan diet can be highly nutritious, as it contains a low amount of saturated fats and a high amount of nutrients. Although meat should be avoided, vegans can get the same nutrients through other alternatives such as tofu, tempeh, and seitan. As for food options, vegans can eat anything with the exception of animal products. Fruits, vegetables, nuts, seeds, and whole grains are the staple of each meal.

Metabolic

Genetics, Diet Quality Independently Linked to T2DM Risk

May 11, 2022

A healthy diet may lower the risk for type 2 diabetes across all levels of genetic risk.

Metabolic

A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease

By

Jessica Nye, PhD

May 10, 2022

The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.

Metabolic

Achieving Treatment Goals in T2DM Can Up Life Expectancy

May 4, 2022

Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D).

Metabolic

Cognitive Behavioral Therapy for Depression Among Patients With Type 2 Diabetes

By

Jessica Nye, PhD

April 29, 2022

Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.

Man taking white pill, medicine, glass of water

Heart Failure

Metformin and Improved Clinical Outcomes in Comorbid Heart Failure and Diabetes

By

Colby Stong

April 26, 2022

Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.

CHD

Determinants of GLP-1 RA Use in Patients With ASCVD and Type 2 Diabetes

By

Sheila Jacobs

April 20, 2022

A study was conducted to examine the relationship between multiple patient factors and use of glucagon-like peptide-1 receptor agonists in patients with ASCVD and T2D.

Metabolic

Depression and HRQOL Influence Disease Trajectory Among Patients With Youth-Onset Type 2 Diabetes

By

Jessica Nye, PhD

April 18, 2022

Investigators assessed whether depressive symptoms, eating disorders, and health-related quality of life were related to a diagnosis of type 2 diabetes in youth and young adults.

Metabolic

Genomics-Enhanced Risk Tools and Polygenic Risk Scores for Coronary Heart Disease and T2D

By

Ron Goldberg

April 15, 2022

Investigators evaluated the effect of genomics-enhanced, questionnaire-based risk tools on polygenic risk scores for coronary heart disease and type 2 diabetes.